Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study

Background and Aim Proton pump inhibitor (PPI)‐induced hypochondria can change the composition of the gut microbiota, inducing overgrowth of small bowel bacteria, which has been suggested to promote the development of fatty liver disease through the gut‐liver axis. In this study, we aimed to investi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of gastroenterology and hepatology 2021-05, Vol.36 (5), p.1235-1243
Hauptverfasser:	Pyo, Jeung Hui, Kim, Tae Jun, Lee, Hyuk, Choi, Sung Chul, Cho, Soo‐Jin, Choi, Yoon‐Ho, Min, Yang Won, Min, Byung‐Hoon, Lee, Jun Haeng, Kang, Minwoong, Lee, Yeong Chan, Kim, Jae J
Format:	Artikel
Sprache:	eng
Schlagworte:	Body mass index Cohort analysis Cohort study Confidence intervals Dosage Drug dosages Fatty liver Fatty liver disease Intestinal microflora Liver diseases Microbiota Proton pump inhibitor Proton pump inhibitors Small intestine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!